Recap: Evaxion Biotech Q2 Earnings

Evaxion Biotech EVAX reported its Q2 earnings results on Wednesday, August 10, 2022 at 08:30 AM.

Here's what investors need to know about the announcement.

Earnings

Evaxion Biotech beat estimated earnings by 33.33%, reporting an EPS of $-0.2 versus an estimate of $-0.3.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.08 which was followed by a 9.42% drop in the share price the next day.

To track all earnings releases for Evaxion Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.